IndyGeneUS Continues to Drive Health Innovation with Latent Knowledge's Advanced AI Technology

WASHINGTON - Amzeal -- IndyGeneUS AI adds Latent Knowledge to its roster of AI innovation partners to power its Precision Health Discovery (PHD) platform, which makes decentralized clinical trials (DCT) research possible through federated data architecture.

Latent Knowledge, a search and knowledge management company, is positioning LitView, its AI search engine, as a means of bringing together disconnected data sources to validate and share a more agile and effective user experience.

As IndyGeneUS collects genomic data and discovers unique gene variants, LitView adds literature-based discovery (LBD) capabilities to help facilitate all research innovations established on the IndyGeneUS PHD platform.

"The current drug development and clinical research landscape is a disconnected ecosystem of literature and patent databases, experimental data, regulatory bottlenecks, and siloed repositories across R&D enterprises," said Yusuf Henriques, CEO & Founder of IndyGeneUs AI. "Utilizing LitView, expedites the linkage of genetic data housed on the PHD to scientific literature."

More on Amzeal News

• Mission Cloud Introduces Mission Cloud Score for AWS Monitoring and Optimization
• Mission Cloud Named 2023 AWS Partner of the Year for Data and Analytics and Security
• Fred Nassiri Relaunches "Love Sees No Colour"
• Economic Impact Catalyst (EIC) Welcomes Kim Vogel as Chief Strategy Officer
• Mississippi SBDC Partners with Economic Impact Catalyst on Critical Research Study

Users of LitView's private beta program, comprised of over 250 global researchers, found articles they couldn't locate on traditional databases using the same keywords and search strategies around drug delivery, public health, mechanical engineering, and entrepreneurship.

"We're excited by the opportunity to work with IndyGeneUS AI as their search and knowledge management partner and contribute to their health equity initiatives with literature based discovery technology," says James Reilly, Latent Knowledge CEO and co-founder.

To support IndyGeneUS AI, LitView will enable literature-based discovery of new and relevant literature around related pathways, biosimilars, alternative treatments, and multidisciplinary innovations to support novel therapeutics.

To learn more about IndyGeneUS visit: https://indygeneus.ai or to learn more about LitView visit: https://www.litview.co. Please direct media inquiries to Angel Livas - angel@indygeneus.ai

More on Amzeal News

• The "AI Adaptability Test" Is Now Available to the Public
• The Samuel Lawrence Foundation Presents Live from Dubai: First Friday Series Webinar on Dec 1
• Wohler makes the Evertz Quartz Protocol available for their iAM-SUM audio monitors & iVAM-SUM AV monitors
• Genuine Hospitality, LLC Adds Two, Southwest Florida Hotels, to Growing Portfolio
• Corrosion protection for electrical systems

IndyGeneUS AI bio

IndyGeneUS AI, a Black and Veteran-owned artificial intelligence-powered digital health company accelerating the discovery, development, and manufacturing of advanced therapeutics to address health disparities impacting African diaspora populations in accessing equitable, precision healthcare.

Latent Knowledge

Latent Knowledge is a search and knowledge management company. Our flagship product, LitView, is a research project manager and search engine for R&D teams that can organize relevant documents and collaborators across disparate stakeholder ecosystems.